Gaithersburg, Maryland
United States
34
2016-06-30
21
2018-01-16
These are the the leading inventors for applications assigned to GLYCOMIMETICS, INC.:
GLYCOMIMETICS, INC. based in Gaithersburg, US has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:
Compounds, compositions and methods using E-selectin antagonists for mobilization of hematopoietic cells
#2 | 2015-10-08E-SELECTIN ANTAGONIST COMPOUNDS AND METHODS OF USE
#3 | 2015-04-23 β Patent 9,109,002 granted on 2015-08-18E-selectin antagonist compounds, compositions, and methods of use
#4 | 2014-06-26HETEROBIFUNCTIONAL PAN-SELECTIN INHIBITORS
#5 | 2014-03-13GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIV
#6 | 2013-12-12 β Patent 8,921,328 granted on 2014-12-30E-selectin antagonists
#7 | 2013-07-18HETEROBIFUNCTIONAL INHIBITORS OF E-SELECTINS AND CXCR4 CHEMOKINE RECEPTORS
#8 | 2012-12-27GLYCOMIMETIC INHIBITORS OF THE PA-IL LECTIN, PA-IIL LECTIN OR BOTH THE LECTINS FROM PSEUDOMONAS
#9 | 2012-08-09METHODS OF USE OF GLYCOMIMETICS WITH REPLACEMENTS FOR HEXOSES AND N-ACETYL HEXOSAMINES
#10 | 2012-01-19 β Patent 8,361,975 granted on 2013-01-29Compounds and methods for treatment of sickle cell or complications associated therewith
#11 | 2012-01-05 β Patent 8,633,303 granted on 2014-01-21Heterobifunctional pan-selectin inhibitors
#12 | 2011-10-20GLYCOMIMETIC REPLACEMENTS FOR HEXOSES AND N-ACETYL HEXOSAMINES
#13 | 2011-10-13GLYCOMIMETIC COMPOUNDS AND METHODS TO INHIBIT INFECTION BY HIV
#14 | 2011-02-03DETECTION AND TREATMENT OF PROSTATE CANCER
#15 | 2010-11-04 β Patent 8,410,066 granted on 2013-04-02Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptors
#16 | 2010-11-04 β Patent 8,530,448 granted on 2013-09-10Compounds and methods for inhibiting selectin-mediated function
#17 | 2010-08-12 β Patent 7,989,601 granted on 2011-08-02Heterobifunctional pan-selectin inhibitors
#18 | 2010-02-18 β Patent 8,258,290 granted on 2012-09-04Glycomimetic inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from
#19 | 2009-12-17 β Patent 8,518,896 granted on 2013-08-27Treatment of cancers of the blood using selected glycomimetic compounds
#20 | 2009-10-08 β Patent 8,895,510 granted on 2014-11-25Pan-selectin inhibitor with enhanced pharmacokinetic activity
#21 | 2009-07-09GALACTOSIDES AND THIODIGALACTOSIDES AS INHIBITORS OF PA-IL LECTIN FROM PSEUDOMONAS
#22 | 2009-07-09GLYCOMIMETIC INHIBITORS OF SIGLEC-8
#23 | 2009-02-05Heterobifunctional compounds for selectin inhibition
#24 | 2009-01-22 β Patent 8,039,442 granted on 2011-10-18Compounds and methods for treatment of sickle cell disease or complications associated therewith
#25 | 2008-08-21 β Patent 8,026,222 granted on 2011-09-27Methods of use of glycomimetics with replacements for hexoses and n-acetyl hexosamines
#26 | 2008-07-03 β Patent 7,964,569 granted on 2011-06-21Glycomimetic replacements for hexoses and N-acetyl hexosamines
#27 | 2007-03-08 β Patent 7,728,117 granted on 2010-06-01Heterobifunctional pan-selectin inhibitors
#28 | 2007-03-01 β Patent 7,727,735 granted on 2010-06-01Detection and treatment of prostate cancer
#29 | 2007-02-15 β Patent 7,517,980 granted on 2009-04-14Glycomimetric inhibitors of the PA-IL lectin, PA-IIL lectin or both the lectins from
#30 | 2006-11-14 β Patent 7,135,301 granted on 2006-11-14Detection and treatment of prostate cancer
#31 | 2006-08-31 β Patent 7,741,312 granted on 2010-06-22Compounds and methods for inhibiting selectin-mediated function
#32 | 2006-06-13 β Patent 7,060,685 granted on 2006-06-13Compounds and methods for inhibiting selectin-mediated function
#33 | 2005-08-25Glycomimetic antagonists for both E-and P-selectins
#34 | 2005-07-28 β Patent 7,361,644 granted on 2008-04-22Specific antagonist for both E- and P-selectins
Also check out GLYCOMIMETICS, INC.'s (Gaithersburg, United States) applicant profile with 3 patent applications submitted.
30893 β